New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Augmedix, Inc.
AUGX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

116M

Medical - Healthcare Information Services

Next Earning date - 04 Nov 2024

116M

Medical - Healthcare Information Services

Next Earning date - 04 Nov 2024

2.35USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

4
favorite-chart

Volume Buzz

-97%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

62%

Quote Panel

Shape
Updated October 12, 2024
1W % 1M 0.86 % 3M 158.84 % 1Y -53.47 %

Key Metrics

Shape
  • Market Cap

    116.16M


  • Shares Outstanding

    49.43M


  • Share in Float

    24.99M


  • Dividende

    0


  • Earning Date

    04 Nov 2024


  • Price Target

    2.35


  • Average Volume

    808771


  • Beta

    -0.19


  • Range

    0.73-6.25


  • Industry

    Medical - Healthcare Information Services


  • Website

    https://www.augmedix.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

2.25x

P/S Ratio

11.98x

P/B Ratio

2.1

Debt/Equity

-46.2%

Net Margin

$-0.5

EPS

How AUGX compares to sector?

P/E Ratio

Relative Strength

Shape

AUGX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$69M

Shape401%

2025-Revenue

$0.47

Shape-197%

2025-EPS

$51M

Shape-520%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

B. Riley

downgrade

Previous: Not converted

2024-07-19

Now: Neutral

William Blair

downgrade

Previous: Not converted

2024-07-19

Now: Market Perform

Evercore ISI

upgrade

Previous: Not converted

2024-04-09

Now: Outperform

Zacks Investment Research

upgrade

Previous: Not converted

2022-04-26

Now: Hold

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.15
vs -0.11

Q4.22

arrow
arrow

N/A

-0.15
vs -0.15

Q1.23

arrow
arrow

N/A

-0.14
vs -0.16

Q2.23

arrow
arrow

N/A

-0.12
vs -0.17

Q3.23

arrow
arrow

N/A

-0.10
vs -0.15

Q4.23

arrow
arrow

N/A

-0.09
vs -0.15

Q1.24

arrow
arrow

N/A

-0.12
vs -0.14

Q2.24

arrow
arrow

N/A

-0.16
vs -0.12

Q3.24

arrow
arrow

N/A

-0.14
vs -0.10

Q4.24

arrow
arrow

N/A

-0.14
vs -0.09

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+40%

7.9M  vs 5.6M

Q4.22

arrow
arrow

+33%

8.8M  vs 6.6M

Q1.23

arrow
arrow

+38%

9.6M  vs 7M

Q2.23

arrow
arrow

+47%

10.8M  vs 7.3M

Q3.23

arrow
arrow

+50%

11.8M  vs 7.9M

Q4.23

arrow
arrow

+45%

12.7M  vs 8.8M

Q1.24

arrow
arrow

+40%

13.5M  vs 9.6M

Q2.24

arrow
arrow

+27%

13.7M  vs 10.8M

Q3.24

arrow
arrow

+10%

13M  vs 11.8M

Q4.24

arrow
arrow

+2%

12.9M  vs 12.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-86%

-0.86
vs -0.79

Q4.22

arrow
arrow

-393%

-3.93
vs -0.86

Q1.23

arrow
arrow

+165%

1.65
vs -3.93

Q2.23

arrow
arrow

-126%

-1.26
vs 1.65

Q3.23

arrow
arrow

-600%

-6.00
vs -1.26

Q4.23

arrow
arrow

-19%

-0.19
vs -6.00

Q1.24

arrow
arrow

-37%

-0.37
vs -0.19

Q2.24

arrow
arrow

-81%

-0.81
vs -0.37

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

27

27
vs 25

8%

Q4.22

arrow
arrow

29

29
vs 27

7%

Q1.23

arrow
arrow

28

28
vs 29

-3%

Q2.23

arrow
arrow

52

52
vs 28

86%

Q3.23

arrow
arrow

68

68
vs 52

31%

Q4.23

arrow
arrow

90

90
vs 68

32%

Q1.24

arrow
arrow

91

91
vs 90

1%

Q2.24

arrow
arrow

54

54
vs 91

-41%

Earnings Growth

Latest News

AUGX

globenewswire.com

8 hours ago